| scholarly article | Q13442814 |
| P50 | author | Electra D Paskett | Q88226762 |
| Amy K. Ferketich | Q110100129 | ||
| P2093 | author name string | Rajesh Balkrishnan | |
| Roger T Anderson | |||
| John M McLaughlin | |||
| Eric E Seiber | |||
| P2860 | cites work | Influence of delay on survival in patients with breast cancer: a systematic review | Q33597775 |
| Factors predicting delayed presentation of symptomatic breast cancer: a systematic review | Q33597780 | ||
| Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites | Q33705480 | ||
| Breast cancer survival among economically disadvantaged women: the influences of delayed diagnosis and treatment on mortality | Q34222510 | ||
| Prognostic implications of emergency admission and delays in patients with breast cancer | Q82235226 | ||
| Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women | Q83048492 | ||
| Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer | Q83515356 | ||
| Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival | Q83963177 | ||
| The clinical stages of breast cancer--what do they mean? | Q35899115 | ||
| A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer | Q35963730 | ||
| The Relative Significance of Prognostic Factors in Breast Carcinoma | Q36040071 | ||
| THE INFLUENCE OF DELAY ON THE NATURAL HISTORY AND PROGNOSIS OF BREAST CANCER: A STUDY OF CASES FOLLOWED FOR FIVE TO TWENTY YEARS. | Q36127482 | ||
| Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? | Q36472202 | ||
| Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer | Q36610623 | ||
| The influence on survival of delay in the presentation and treatment of symptomatic breast cancer | Q36618888 | ||
| Practical considerations on the use of the Charlson comorbidity index with administrative data bases | Q36841620 | ||
| Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897 | Q37171287 | ||
| Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly | Q37399708 | ||
| Reasons for delay in breast cancer diagnosis | Q39432747 | ||
| Primary invasive breast carcinoma in Oslo 1980-1989. Incidence and delay | Q40981380 | ||
| Delay, stage of disease and survival from breast cancer | Q41630402 | ||
| Patient's and doctor's delay in primary breast cancer. Prognostic implications | Q43533936 | ||
| The impact of confounder selection criteria on effect estimation | Q43670469 | ||
| The role of Hispanic race/ethnicity and poverty in breast cancer survival. | Q46120595 | ||
| Breast cancer treatment in older women: impact of the patient-physician interaction | Q46213711 | ||
| Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer | Q46309503 | ||
| Delays in breast cancer diagnosis and treatment by racial/ethnic group | Q46712892 | ||
| Parity and disparity in first course treatment of invasive breast cancer | Q46785864 | ||
| Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma | Q50113161 | ||
| Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. | Q53901336 | ||
| Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995 | Q64131036 | ||
| Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005 | Q64131632 | ||
| A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer | Q67040783 | ||
| Breast self-examination and survival from breast cancer | Q68502497 | ||
| Diagnostic delay in breast cancer: correlation with disease stage and prognosis | Q68672952 | ||
| Does delay in diagnosis of breast cancer affect survival? | Q68747786 | ||
| Relation between delay and survival in 596 patients with breast cancer | Q69592212 | ||
| Delay in the treatment of carcinoma of the breast | Q70098283 | ||
| Delay in diagnosis and long-term survival in breast cancer | Q71234765 | ||
| The effects of patient delay and symptoms other than a lump on survival in breast cancer | Q71661406 | ||
| Delay, stage of disease, and survival among White and Black women with breast cancer | Q71700016 | ||
| The effects of delay in treatment of survival rates in carcinoma of the breast | Q71767007 | ||
| A 15-year follow-up study of patients treated for carcinoma of the breast | Q72029906 | ||
| The significance of delay in relation to prognosis of patients with primary operable breast cancer | Q74488564 | ||
| FACTORS INFLUENCING THE SURVIVAL OF PATIENTS WITH CARCINOMA OF THE BREAST | Q76563183 | ||
| Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis | Q77345778 | ||
| Delay in diagnosis of breast cancer | Q77922707 | ||
| Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma | Q79747352 | ||
| Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma | Q79899271 | ||
| Racial disparities in treatment and survival among women with early-stage breast cancer | Q81231665 | ||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 4493-4500 | |
| P577 | publication date | 2012-11-19 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer | |
| P478 | volume | 30 |
| Q38470766 | A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change |
| Q40457217 | A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference? |
| Q39438238 | Access to Care in Vermont: Factors Linked With Time to Chemotherapy for Women With Breast Cancer-A Retrospective Cohort Study |
| Q39609328 | Are disparities of waiting times for breast cancer care related to socio-economic factors? A regional population-based study (France). |
| Q33841552 | Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands. |
| Q35112817 | Breast cancer treatment among African American women in north St. Louis, Missouri |
| Q35193456 | Breast cancer treatment delays in a majority minority community: is there a difference? |
| Q34091245 | Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program |
| Q64273180 | Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country |
| Q34023713 | Challenges to the early diagnosis and treatment of breast cancer in developing countries |
| Q35675550 | Characteristics of the Delayed or Refusal Therapy in Breast Cancer Patients: A Longitudinal Population-Based Study in Taiwan. |
| Q30490752 | Characterizing breast conditions at an open-access breast clinic in South Africa: a model that is more than cancer care for a resource-limited setting |
| Q37613953 | Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer |
| Q51205753 | Commercial insurance triples chances of breast cancer survival in a public hospital. |
| Q33965584 | Delay in breast cancer: implications for stage at diagnosis and survival |
| Q37097569 | Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer |
| Q40219720 | Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer |
| Q60922855 | Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis |
| Q37035464 | Determinants of breast cancer treatment delay differ for African American and White women |
| Q35641695 | Diagnosis and surgical delays in African American and white women with early-stage breast cancer |
| Q38670929 | Diagnosis and treatment delays among elderly breast cancer patients with pre-existing mental illness |
| Q59478489 | Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer |
| Q92203284 | Effect of Sociodemographic Variables on Patient and Diagnostic Delay of Breast Cancer at the Foremost Health Care Institution in Nigeria |
| Q40933656 | Effect of waiting time for radiotherapy on five-year overall survival in women with cervical cancer, 1995-2010 |
| Q35248415 | Effects of payer status on breast cancer survival: a retrospective study |
| Q40499819 | Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities |
| Q34565516 | Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study |
| Q48148913 | Factors influencing time to seeking medical advice and onset of treatment in women who are diagnosed with breast cancer in Serbia |
| Q90261370 | How European primary care practitioners think the timeliness of cancer diagnosis can be improved: a thematic analysis |
| Q57160501 | Identifying important health system factors that influence primary care practitioners' referrals for cancer suspicion: a European cross-sectional survey |
| Q28082544 | Impact of Age and Comorbidity on Cervical and Breast Cancer Literacy of African Americans, Latina, and Arab Women |
| Q38709408 | Impact of Medicaid disenrollment in Tennessee on breast cancer stage at diagnosis and treatment. |
| Q89694389 | Impact of delayed treatment in women diagnosed with breast cancer: A population-based study |
| Q47106454 | Impact of patient demographics, tumor characteristics, and treatment type on treatment delay throughout breast cancer care at a diverse academic medical center. |
| Q33813179 | Impact of patient navigation on timely cancer care: the Patient Navigation Research Program |
| Q27000171 | Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review |
| Q36205585 | Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival |
| Q90286872 | Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy |
| Q36085654 | Patient Navigation in Breast Cancer Treatment and Survivorship: A Systematic Review |
| Q34997370 | Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL |
| Q64117540 | Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a qualitative study |
| Q40382440 | Private Payer's Status Improves Male Breast Cancer Survival |
| Q90092863 | Provider delay in treatment initiation and its influence on survival outcomes in women with operable breast cancer |
| Q52674068 | Quality Of Breast Cancer Care In The US Territories: Insights From Medicare. |
| Q57108049 | Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis |
| Q37629494 | Reducing time-to-treatment in underserved Latinas with breast cancer: the Six Cities Study. |
| Q37638649 | Regional differences in breast cancer biomarkers in american Indian and Alaska native women |
| Q102132737 | Relationship between insurance status and outcomes for patients with breast cancer in Missouri |
| Q40680595 | Surveillance of waiting times for access to treatment: a registry-based computed approach in breast cancer care |
| Q46399001 | Survival of patients with metastatic breast cancer with or without locoregional therapy |
| Q30274959 | The Effects of Hospital Characteristics on Delays in Breast Cancer Diagnosis in Appalachian Communities: A Population-Based Study |
| Q55317100 | The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women. |
| Q35056470 | The impact of insurance coverage during insurance reform on diagnostic resolution of cancer screening abnormalities. |
| Q36081257 | The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis |
| Q91903862 | The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer |
| Q30707238 | The role of private care in the interval between diagnosis and treatment of breast cancer in Northern Ireland: an analysis of Registry data |
| Q40136684 | Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma |
| Q39257286 | Time from Screening Mammography to Biopsy and from Biopsy to Breast Cancer Treatment among Black and White, Women Medicare Beneficiaries Not Participating in a Health Maintenance Organization. |
| Q36678065 | Time to Surgery and Breast Cancer Survival in the United States. |
| Q45328775 | Time trends in population-based breast cancer survival in Estonia: analysis by age and stage |
| Q57105011 | Timing and Delays in Breast Cancer Evaluation and Treatment |
| Q50126412 | Treatment delay for Māori women with breast cancer in New Zealand |
| Q36916800 | Treatment of breast cancer patients from a public healthcare system in a private center: costs of care for a pilot public-private partnership in oncology |
| Q64286680 | Trends and Outcomes of Non-compliance with Treatment for Gastric Cancer in Korea over the 16 years from 1999 to 2015 |
| Q37281066 | Tumour cells coerce host tissue to cancer spread |
| Q31080159 | Using big data for quality assessment in oncology |
| Q43202165 | Wait times from diagnosis to treatment in cancer |
| Q47339353 | ÖGRO survey on radiotherapy capacity in Austria : Status quo and estimation of future demands |
Search more.